| Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. | oral |
| Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. | prostate, |
| Primary malignant lymphoma of the brain: analysis of MMAC1 (PTEN) tumor suppressor gene. | lymphoma,brain, |
| Loss of tumor suppressor protein PTEN during renal carcinogenesis. | kidney, |
| MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. | prostate, |
| Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. | thyroid, |
| PTEN inactivation may be important for the propagation of melanoma cells in culture, and that another chromosome 10 tumour suppressor gene may be important for melanoma pathogenesis. | skin, |
| Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. | gastric, |
| Data suggest that PTEN tumor suppressor gene malfunction seems to be involved in metastasing capacity of hepatocellular carcinoma. | liver, |
| Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. | prostate, |
| Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression. | ovarian, |
| PTEN is haploinsufficient in a mouse model of prostate tumor suppression | prostate, |
| PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma. | sarcoma, |
| a role of these tumor suppressor and metastasis suppressor genes in the evolution and progression of NSCLC | lung, |
| Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. | prostate, |
| Data show that PTEN and MXI1 were two candidate tumor suppressor genes on 10q23 and 10q24-q25 and may be potentially involved in the initiation and progression of prostate carcinoma. | prostate, |
| The Tumor suppressor PTEN was involved in control of VEGF/VEGFR-2 stimulated prostate cancer cell adhesion as well as proliferation. | prostate, |
| Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. | gastric, |
| An increase in GRP binding capacity, as a result of GRP-R overexpression, down-regulates PTEN expression. Inhibition of the tumor suppressor gene PTEN may be an important regulatory mechanism involved in GRP-induced cell proliferation in neuroblastomas. | neuroblastoma, |
| We demonstrate that the expression of the tumor suppressor gene PTEN has a significant inverse correlation with fatty acid synthase (FAS) expression in prostate cancer, and inhibition of the PTEN gene leads to the overexpression of FAS in vitro. | prostate, |